We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Patient Recruitment for Clinical Trials

By Biotechdaily staff writers
Posted on 06 Nov 2002
A new strategic alliance will provide an enhanced suite of web-enabled patient recruitment solutions for pharmaceutical and biotechnology clinical trial sponsors. More...


Veritas Medicine (Cambridge, MA, USA) and Harris Interactive (Rochester, NY, USA) have formed an alliance to create and provide a comprehensive range of new services. These include the Veritas Medicine web-based screening and recruitment platforms and Harris Interactive's expanded healthcare database offerings, with its Chronic Illness panel of 800,000+ households. By leveraging technology, the two companies will provide protocol feasibility testing; online screening, referral, and retention; and other services designed to increase the effectiveness of patient recruitment. Clinical trial sponsors will now be able to access these services through a single source.

"Our respective patient recruitment services are complementary,” noted Dr. Joseph Avellone, CEO of Veritas Medicine. "Working together, Harris Interactive and Veritas Medicine can now offer a seamless, integrated suite of recruitment services that will provide our clients with greater flexibility, and ultimately, more highly qualified patients.”

Dr. Avellone added that online recruitment is the next big change coming to the clinical studies services marketplace. It saves time, saves money, and increases the satisfaction level of the patients who participate in a clinical study.




Related Links:
Veritas Medicine
Harris Interactive

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Chromogenic Culture System
InTray™ COLOREX™ ECC
Japanese Encephalitis Test
Japanese Encephalitis Virus Real Time PCR Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Alzheimer’s pathology can start 15 to 20 years before symptoms, and validated tools that reach patients earlier help pave the way for earlier detection. (Image Credit: Adobe Stock)

Alzheimer’s Blood Test Becomes First FDA-Cleared Option for Adults as Young as 40

C2N Diagnostics’ PrecivityAD2 blood test was cleared by the U.S. Food and Drug Administration (FDA) on August 20, 2026, for adults as young as 40 who are experiencing signs of cognitive impairment, according... Read more

Pathology

view channel
Image: Adrenal gland tumor stained with hematoxylin and eosin (top) and CYP11B2 (bottom) (Photo courtesy of Christofer Juhlin)

Simple Immunohistochemical Size Ratio Improves Classification of Primary Aldosteronism

Primary aldosteronism is a common but underdiagnosed cause of hypertension, in which excess aldosterone promotes salt retention and raises blood pressure. Identifying the dominant source of hormone overproduction... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.